Page last updated: 2024-08-24

topotecan and nvp-aew541

topotecan has been researched along with nvp-aew541 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bonzi, MC; Craparotta, I; Gariboldi, MB; Mancini, M; Monti, E; Pagin, M; Taiana, E	1

Other Studies

1 other study(ies) available for topotecan and nvp-aew541

Article	Year
Co-targeting the IGF system and HIF-1 inhibits migration and invasion by (triple-negative) breast cancer cells. British journal of cancer, 2014, Jun-10, Volume: 110, Issue:12 Topics: Antibodies, Monoclonal; Cell Hypoxia; Cell Line, Tumor; Cell Movement; Female; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; MCF-7 Cells; Pyrimidines; Pyrroles; Receptor, IGF Type 1; Signal Transduction; Topoisomerase I Inhibitors; Topotecan; Triple Negative Breast Neoplasms	2014

Article

Year

Co-targeting the IGF system and HIF-1 inhibits migration and invasion by (triple-negative) breast cancer cells.

British journal of cancer, 2014, Jun-10, Volume: 110, Issue:12

Topics: Antibodies, Monoclonal; Cell Hypoxia; Cell Line, Tumor; Cell Movement; Female; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; MCF-7 Cells; Pyrimidines; Pyrroles; Receptor, IGF Type 1; Signal Transduction; Topoisomerase I Inhibitors; Topotecan; Triple Negative Breast Neoplasms

2014